Skip to content

The latest company news, press releases, and resources about Servier and everything our company has to offer.

Advanced Search
  • servier logo
     
    10.12.2020
    Servier and CureMatch® Launch Their Self-Certified CE-Marked Clinical Decision Support Software, Bionov™
  • servier logo
     
    09.24.2020
    Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket
  • servier logo
     
    09.21.2020
    Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients
  • servier logo
     
    06.12.2020
    Agios and Royalty Pharma Announce $255 Million Purchase Agreement for IDHIFA® Royalty
  • servier logo
     
    05.29.2020
    Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma
Media Contacts

Servier Media Relations
us2mediarelations@servier.com

Subscribe